Clinical Trial

Impact of a Daily Application of an Omega-3 Monoglycerides Based Serum and Cream on the Skin Microbiota

Study acronym: COS-PBP-03
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This exploratory study aims to investigate the prebiotic potential of daily application of an omega-3 serum and cream to skin affected by eczema. The study will also collect data on any potential adverse effects of the products. Ten subjects will be enrolled in the study and will receive the same treatment for fourteen days. Their baseline condition before treatment will serve as a control for the effects observed after treatment on the targeted eczema area. A second area of eczema treated with the patient's usual skincare routine will also serve as a control.
Trial Details
NCT Number NCT07583121
Lead Sponsor SCF Pharma
Conditions Eczema
Enrollment 10 participants
Start Date 2026-05-04
Primary Completion 2026-12-04 (estimated)
Study Completion 2026-12-18 (estimated)
Updated on ClinicalTrials.gov 2026-05-13